Mobia Medical, INC

Mobia Medical announced a robust second quarter for 2026, with revenue soaring 102% year-over-year to $13.5 million, driven by increased adoption of its Vivistim System.

Mobia Medical, Inc. has expanded its Board of Directors by appointing Dr. Myriam J. Curet, a seasoned executive with extensive experience in medical technology and surgery.

Mobia Medical, Inc. has expanded its Board of Directors to seven members with the appointment of Dr. Reza Zadno, who will also serve on the Compensation Committee.

Mobia Medical, Inc. (MOBI) announced a significant increase in revenue for the second quarter of 2026, driven by strong adoption of its Vivistim System, following its successful Initial Public Offering.

Casey M Tansey, a Director of Mobia Medical, Inc., purchased 68,559 shares of common stock on August 13, 2026.

Myriam Curet, a Director of Mobia Medical, Inc., reported multiple transactions in common stock on July 30, 2026.

Reza Zadno, a Director of Mobia Medical, Inc., reported multiple transactions in common stock on July 14, 2026.

Mobi Medical, Inc. reports significant insider transactions involving the conversion of preferred stock and convertible notes into common stock, coinciding with the company's initial public offering.

Mobia Medical, Inc. (MOBI) reports significant insider transactions and beneficial ownership changes following the conversion of preferred stock into common stock.

Several entities and individuals associated with Green Park & Golf Ventures II, LLC reported significant changes in beneficial ownership of Mobia Medical, Inc. common stock.

U.S. Venture Partners and related entities have disclosed their beneficial ownership of Mobia Medical, Inc. common stock, representing a significant stake.